PMI reports double-digit adjusted EPS growth in Q2
Philip Morris International reported Q2 net revenues up 10.4% to $11.2bn and adjusted diluted EPS up 15.2% to $2.20, or 13.6% excluding currency. Reported diluted EPS fell 7.7% to $1.80 after a $511m non-cash impairment tied to its RBH investment. PMI raised its full-year adjusted EPS outlook, citing smoke-free momentum.
How this was made
The 30-second read
Why it matters
The combination of record Q2 revenues, strong smoke-free shipment growth, and a raised full-year adjusted EPS outlook is a direct catalyst for PM’s forward earnings expectations, partially offset by a non-cash RBH impairment affecting reported EPS.
Market read
A fresh Q2 print with a raised full-year adjusted EPS outlook can shift PM’s valuation expectations, especially for investors focused on smoke-free growth durability.
What to watch
The outlook raise is described as driven by currency; traders may discount durability if FX reverses, and may watch for continued Japan/Poland regulatory impacts on in-market sales.
Background
PMI’s earnings mix is increasingly driven by smoke-free products (IQOS heated tobacco, VEEV e-vapour, ZYN nicotine pouches) alongside ongoing combustible volume trends.
Ticker impact
PMI reported Q2 net revenues up 10.4% to $11.2B and raised full-year adjusted diluted EPS outlook for currency effects.
Likely positive bias for PM shares, though impairment and reported EPS decline may cap upside.
The article discloses specific Q2 performance metrics and an explicit full-year adjusted EPS outlook raise, which are direct valuation inputs; the impairment is non-cash but still affects reported EPS.
Market effects
Reinforces the tobacco sector read-through that smoke-free portfolios can offset combustible volume softness and regulatory headwinds.
Highlights Japan and Poland flavor-ban headwinds, implying regional variability in nicotine/tobacco demand.
Supports broader investor confidence in multinational tobacco earnings resilience amid geopolitical cost pressures.
Counterpoint
Reported diluted EPS fell 7.7% due to a non-cash impairment, which could temper enthusiasm despite adjusted growth.
Key entities
- companyPhilip Morris International
Reported Q2 net revenues of $11.2B, adjusted diluted EPS of $2.20, and raised full-year adjusted diluted EPS outlook for currency.
- productIQOS
Heated tobacco platform; unit shipments rose 7.6% and maintained about three-quarters of the global heated tobacco category by volume.
- productZYN
Nicotine pouch brand; FDA MRTP authorization cited for 20 variants and availability expanded to 60 markets.
- investmentRBH (Rothmans, Benson & Hedges)
PMI recorded a $511M non-cash impairment charge tied to updated projections for its Canadian affiliate investment.
